Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail

R. Adam, Douglas Robert Drummond, N. Solic, S. J. Holt, R. P. Sharma, S. G. Chamberlin, D. E. Davies

研究成果: ジャーナルへの寄稿記事

31 引用 (Scopus)

抄録

Amphiregulin (AR), a heparin-binding, epidermal growth factor (EGF) receptor ligand has homology with EGF but exhibits a lower affinity for the EGF receptor than EGF. As the mature form of AR is truncated at the C terminus and lacks a conserved leucine residue known to be essential for high affinity binding of EGF to the EGF receptor, wild-type AR (AR1-84), a C-terminally extended AR construct incorporating six residues from the predicted coding sequence of AR (AR1-90) and a similarly extended construct with a Met86 to Leu substitution (AR1-90(leu86)) were expressed as recombinant proteins in yeast, purified by heparin affinity and C18 reverse phase chromatography and their relative biological activities determined. The growth factors were tested in mitogenesis and EGF receptor autophosphorylation assays and their relative order of potencies was found to be leu86 > met86 > wt. The AR1-90(leu86) construct was found to be 50- to 100-fold more active than wild type AR1-84 consistent with previously reported studies of the role of the equivalent C-terminal leucine in EGF or TGFα. Significantly, the C-terminally extended form of AR, AR1-90, which utilized six residues from the predicted coding sequence, was 10-times more active than wild type AR1-84. This difference in activity of the C-terminally extended form of AR may be of biological significance since differential proteolytic processing of the AR precursor in vivo could result in production of multiple forms of the growth factor with differing affinities for the EGF receptor and hence differing biological potencies.

元の言語英語
ページ(範囲)83-90
ページ数8
ジャーナルBBA - Molecular Cell Research
1266
発行部数1
DOI
出版物ステータス出版済み - 4 6 1995

Fingerprint

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Leucine
Heparin
Intercellular Signaling Peptides and Proteins
Amphiregulin
Reverse-Phase Chromatography
Recombinant Proteins
Yeasts
Ligands

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

これを引用

Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. / Adam, R.; Drummond, Douglas Robert; Solic, N.; Holt, S. J.; Sharma, R. P.; Chamberlin, S. G.; Davies, D. E.

:: BBA - Molecular Cell Research, 巻 1266, 番号 1, 06.04.1995, p. 83-90.

研究成果: ジャーナルへの寄稿記事

Adam, R. ; Drummond, Douglas Robert ; Solic, N. ; Holt, S. J. ; Sharma, R. P. ; Chamberlin, S. G. ; Davies, D. E. / Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. :: BBA - Molecular Cell Research. 1995 ; 巻 1266, 番号 1. pp. 83-90.
@article{d2fe8e890fc640eda16d8f2e6b042107,
title = "Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail",
abstract = "Amphiregulin (AR), a heparin-binding, epidermal growth factor (EGF) receptor ligand has homology with EGF but exhibits a lower affinity for the EGF receptor than EGF. As the mature form of AR is truncated at the C terminus and lacks a conserved leucine residue known to be essential for high affinity binding of EGF to the EGF receptor, wild-type AR (AR1-84), a C-terminally extended AR construct incorporating six residues from the predicted coding sequence of AR (AR1-90) and a similarly extended construct with a Met86 to Leu substitution (AR1-90(leu86)) were expressed as recombinant proteins in yeast, purified by heparin affinity and C18 reverse phase chromatography and their relative biological activities determined. The growth factors were tested in mitogenesis and EGF receptor autophosphorylation assays and their relative order of potencies was found to be leu86 > met86 > wt. The AR1-90(leu86) construct was found to be 50- to 100-fold more active than wild type AR1-84 consistent with previously reported studies of the role of the equivalent C-terminal leucine in EGF or TGFα. Significantly, the C-terminally extended form of AR, AR1-90, which utilized six residues from the predicted coding sequence, was 10-times more active than wild type AR1-84. This difference in activity of the C-terminally extended form of AR may be of biological significance since differential proteolytic processing of the AR precursor in vivo could result in production of multiple forms of the growth factor with differing affinities for the EGF receptor and hence differing biological potencies.",
author = "R. Adam and Drummond, {Douglas Robert} and N. Solic and Holt, {S. J.} and Sharma, {R. P.} and Chamberlin, {S. G.} and Davies, {D. E.}",
year = "1995",
month = "4",
day = "6",
doi = "10.1016/0167-4889(94)00224-3",
language = "English",
volume = "1266",
pages = "83--90",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail

AU - Adam, R.

AU - Drummond, Douglas Robert

AU - Solic, N.

AU - Holt, S. J.

AU - Sharma, R. P.

AU - Chamberlin, S. G.

AU - Davies, D. E.

PY - 1995/4/6

Y1 - 1995/4/6

N2 - Amphiregulin (AR), a heparin-binding, epidermal growth factor (EGF) receptor ligand has homology with EGF but exhibits a lower affinity for the EGF receptor than EGF. As the mature form of AR is truncated at the C terminus and lacks a conserved leucine residue known to be essential for high affinity binding of EGF to the EGF receptor, wild-type AR (AR1-84), a C-terminally extended AR construct incorporating six residues from the predicted coding sequence of AR (AR1-90) and a similarly extended construct with a Met86 to Leu substitution (AR1-90(leu86)) were expressed as recombinant proteins in yeast, purified by heparin affinity and C18 reverse phase chromatography and their relative biological activities determined. The growth factors were tested in mitogenesis and EGF receptor autophosphorylation assays and their relative order of potencies was found to be leu86 > met86 > wt. The AR1-90(leu86) construct was found to be 50- to 100-fold more active than wild type AR1-84 consistent with previously reported studies of the role of the equivalent C-terminal leucine in EGF or TGFα. Significantly, the C-terminally extended form of AR, AR1-90, which utilized six residues from the predicted coding sequence, was 10-times more active than wild type AR1-84. This difference in activity of the C-terminally extended form of AR may be of biological significance since differential proteolytic processing of the AR precursor in vivo could result in production of multiple forms of the growth factor with differing affinities for the EGF receptor and hence differing biological potencies.

AB - Amphiregulin (AR), a heparin-binding, epidermal growth factor (EGF) receptor ligand has homology with EGF but exhibits a lower affinity for the EGF receptor than EGF. As the mature form of AR is truncated at the C terminus and lacks a conserved leucine residue known to be essential for high affinity binding of EGF to the EGF receptor, wild-type AR (AR1-84), a C-terminally extended AR construct incorporating six residues from the predicted coding sequence of AR (AR1-90) and a similarly extended construct with a Met86 to Leu substitution (AR1-90(leu86)) were expressed as recombinant proteins in yeast, purified by heparin affinity and C18 reverse phase chromatography and their relative biological activities determined. The growth factors were tested in mitogenesis and EGF receptor autophosphorylation assays and their relative order of potencies was found to be leu86 > met86 > wt. The AR1-90(leu86) construct was found to be 50- to 100-fold more active than wild type AR1-84 consistent with previously reported studies of the role of the equivalent C-terminal leucine in EGF or TGFα. Significantly, the C-terminally extended form of AR, AR1-90, which utilized six residues from the predicted coding sequence, was 10-times more active than wild type AR1-84. This difference in activity of the C-terminally extended form of AR may be of biological significance since differential proteolytic processing of the AR precursor in vivo could result in production of multiple forms of the growth factor with differing affinities for the EGF receptor and hence differing biological potencies.

UR - http://www.scopus.com/inward/record.url?scp=0028898965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028898965&partnerID=8YFLogxK

U2 - 10.1016/0167-4889(94)00224-3

DO - 10.1016/0167-4889(94)00224-3

M3 - Article

C2 - 7718625

AN - SCOPUS:0028898965

VL - 1266

SP - 83

EP - 90

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 1

ER -